Brandes Investment Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-6,212
| Closed | -$1.12M | – | 182 |
|
|
2025
Q2 | $1.12M | Buy |
6,212
+325
| +6% | +$56.5K | 0.01% | 166 |
|
|
2025
Q1 | $996K | Sell |
5,887
-4,893
| -45% | -$804K | 0.01% | 165 |
|
|
2024
Q4 | $1.63M | Buy |
10,780
+1,159
| +12% | +$180K | 0.02% | 152 |
|
|
2024
Q3 | $1.49M | Buy |
9,621
+1,324
| +16% | +$198K | 0.02% | 146 |
|
|
2024
Q2 | $1.14M | Buy |
8,297
+2,320
| +39% | +$318K | 0.01% | 148 |
|
|
2024
Q1 | $796K | Buy |
5,977
+2,739
| +85% | +$355K | 0.01% | 151 |
|
|
2023
Q4 | $446K | Buy |
+3,238
| New | +$426K | 0.01% | 159 |
|
|
2022
Q4 | – | Sell |
-6,720
| Closed | -$825K | – | 146 |
|
|
2022
Q3 | $825K | Sell |
6,720
-28
| -0.4% | -$3.69K | 0.02% | 137 |
|
|
2022
Q2 | $897K | Sell |
6,748
-9
| -0.1% | -$1.23K | 0.02% | 133 |
|
|
2022
Q1 | $924K | Hold |
6,757
| – | – | 0.02% | 131 |
|
|
2021
Q4 | $1.17M | Sell |
6,757
-509
| -7% | -$77.4K | 0.03% | 133 |
|
|
2021
Q3 | $1.06M | Sell |
7,266
-122
| -2% | -$17.9K | 0.02% | 128 |
|
|
2021
Q2 | $975K | Buy |
7,388
+8
| +0.1% | +$1.05K | 0.02% | 128 |
|
|
2021
Q1 | $948K | Sell |
7,380
-233
| -3% | -$28.7K | 0.02% | 125 |
|
|
2020
Q4 | $901K | Sell |
7,613
-107
| -1% | -$13K | 0.02% | 125 |
|
|
2020
Q3 | $884K | Sell |
7,720
-1,877
| -20% | -$222K | 0.03% | 128 |
|
|
2020
Q2 | $1.09M | Sell |
9,597
-312
| -3% | -$33.1K | 0.03% | 130 |
|
|
2020
Q1 | $796K | Sell |
9,909
-613
| -6% | -$63.5K | 0.03% | 118 |
|
|
2019
Q4 | $1.12M | Sell |
10,522
-636
| -6% | -$66.3K | 0.03% | 109 |
|
|
2019
Q3 | $1.19M | Sell |
11,158
-537
| -5% | -$55.1K | 0.03% | 106 |
|
|
2019
Q2 | $1.19M | Sell |
11,695
-281
| -2% | -$27K | 0.03% | 105 |
|
|
2019
Q1 | $1.08M | Buy |
11,976
+6,497
| +119% | +$563K | 0.03% | 109 |
|
|
2018
Q4 | $456K | Buy |
5,479
+3,530
| +181% | +$331K | 0.01% | 126 |
|
|
2018
Q3 | $210K | Buy |
1,949
+110
| +6% | +$12.1K | ﹤0.01% | 139 |
|
|
2018
Q2 | $202K | Buy |
+1,839
| New | +$192K | ﹤0.01% | 136 |
|
|
2017
Q2 | – | Sell |
-78,932
| Closed | -$7.75M | – | 193 |
|
|
2017
Q1 | $7.75M | Sell |
78,932
-62,781
| -44% | -$5.98M | 0.12% | 88 |
|
|
2016
Q4 | $13M | Buy |
141,713
+179
| +0.1% | +$15.4K | 0.2% | 76 |
|
|
2016
Q3 | $12M | Sell |
141,534
-5,260
| -4% | -$442K | 0.18% | 77 |
|
|
2016
Q2 | $12M | Sell |
146,794
-15,891
| -10% | -$1.21M | 0.18% | 79 |
|
|
2016
Q1 | $11.6M | Sell |
162,685
-6,300
| -4% | -$422K | 0.17% | 82 |
|
|
2015
Q4 | $12M | Sell |
168,985
-1,437
| -0.8% | -$96.6K | 0.18% | 80 |
|
|
2015
Q3 | $10.5M | Sell |
170,422
-1,909
| -1% | -$133K | 0.15% | 80 |
|
|
2015
Q2 | $12.5M | Sell |
172,331
-2,383
| -1% | -$176K | 0.16% | 76 |
|
|
2015
Q1 | $13.4M | Sell |
174,714
-11,399
| -6% | -$816K | 0.18% | 74 |
|
|
2014
Q4 | $12.5M | Buy |
+186,113
| New | +$11.7M | 0.18% | 77 |
|
Other funds holding DGX
Brandes Investment Partners's DGX Position: Q3 2025 in Review
Brandes Investment Partners sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 6,212 shares — an estimated $1.12M sold.
Brandes Investment Partners first reported a position in DGX in Q4 2014 and held it in 35 quarters. The position peaked at $13.4M in Q1 2015. 1,006 funds tracked by Wall St. Rank hold DGX as of Q3 2025.
- Brandes Investment Partners reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
- Brandes Investment Partners sold 6,212 Quest Diagnostics shares in Q3 2025, an estimated $1.12M.
- Brandes Investment Partners first reported a position in Quest Diagnostics in Q4 2014 and held it in 35 quarters.
- Brandes Investment Partners's Quest Diagnostics position peaked at $13.4M in Q1 2015.
- 1,006 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.
Based on Brandes Investment Partners's 13F filing for Q3 2025, filed 14 Nov 2025.